Epistemix
United States
- Pittsburgh, Pennsylvania
- 01/03/2022
- Seed
- $5,000,000
Epistemix is a leading provider of analytical tools that empower leaders to make better decisions by simulating how diseases, ideas, and behavior spread through communities. We leverage decades of epidemiological experience, diverse datasets, realistic population dynamics, and scientific best-practice to build computational models that forecast the human impacts of policy interventions, so that organizations can take informed action. Our simulations have been used by groups like the Centers for Disease Control, the National Institutes of Health, and the World Health Organization. We are currently working with companies, event organizers, schools, and state and local governments across the United States to evaluate opening strategies and gauge COVID-19 response.
- Industry Software Development
- Website https://www.epistemix.com/
- LinkedIn https://www.linkedin.com/company/epistemix/
Related People
John CordierCo Founder
United States -
Pittsburgh, Pennsylvania
Working to improve conditions for people to live better lives.
Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
IORGANBIO | $2,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)